Fibromyalgia Secondary to PTSD

Why the secondary pathway is plausible

Peer-reviewed literature consistently identifies fibromyalgia in PTSD populations at rates several times higher than the general public. The proposed mechanisms — chronic HPA-axis activation, sustained sympathetic tone, central sensitization, and disrupted REM sleep — are well-documented in the rheumatology and psychiatry literatures.

A nexus opinion typically frames the issue as 'at least as likely as not' that the veteran's PTSD caused or aggravated fibromyalgia through one or more of those mechanisms.

Rating criteria — DC 5025

• 10% — symptoms require continuous medication for control.
• 20% — symptoms are episodic, with exacerbations often precipitated by environmental or emotional stress or by overexertion, but that are present more than one-third of the time.
• 40% — symptoms are constant, or nearly so, and refractory to therapy.

Gulf War overlap (38 CFR § 3.317)

For Gulf War-era veterans, fibromyalgia is one of the specifically listed presumptive medically unexplained chronic multisymptom illnesses (MUCMI) under § 3.317. If you served in the Southwest Asia theater of operations during the qualifying period, you may have two pathways available: direct presumptive under § 3.317 and secondary-to-PTSD under § 3.310. They are not mutually exclusive — claim both and let VA choose the most favorable theory.

Evidence that strengthens the claim

• Established service connection for PTSD (or another qualifying mental health condition).
• Formal fibromyalgia diagnosis from a rheumatologist or other qualified provider, ideally citing American College of Rheumatology criteria (widespread pain index + symptom severity score).
• A nexus opinion explicitly addressing the PTSD → fibromyalgia mechanism (central sensitization, HPA-axis dysregulation, autonomic dysfunction).
• Symptom log documenting pain location, frequency, sleep disturbance, cognitive symptoms ('fibro fog'), and impact on daily activities.
• Records showing medication trials and response — supports the 'continuous medication' or 'refractory' rating language.

Common pitfalls

Examiners sometimes attribute widespread pain to another orthopedic condition and miss the fibromyalgia diagnosis entirely. If you have a rheumatology diagnosis, bring it to the C&P exam. Conversely, a C&P examiner cannot rule out fibromyalgia simply because tender-point testing was once-popular and now disfavored — the ACR has moved on, and the rating schedule does not require tender-point counts.

Where these claims break down

• ×Claiming only the secondary theory when the Gulf War presumptive is available — file both.
• ×Showing up to a C&P exam without the rheumatology diagnosis in hand.
• ×Letting the C&P examiner conflate fibromyalgia with degenerative joint disease.
• ×Failing to document continuous medication use — it is the floor for a compensable rating.

Frequently Asked Questions